JMPLY
Johnson Matthey Plc [JMPLY] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
JMPLY Stock Summary
Top JMPLY Correlated Resources
JMPLY
Top 10 Correlated ETFs
JMPLY
Top 10 Correlated Stocks
JMPLY
In the News
Johnson Matthey (JMPLY) Sells Medical Device Unit for $700M
Johnson Matthey (JMPLY) finalizes the sale of its Medical Device Components business to Montagu Private Equity for $700 million, completing its Value Businesses divestment program.
Is Johnson Matthey (JMPLY) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
UK's Johnson Matthey to sell medical device business for $700 mln
Britain's Johnson Matthey (JM) will sell its medical device components business to Montagu Private Equity for $700 million in cash, as part of its strategy to focus on growth units and streamline operations.
Johnson Matthey sells medical device components business
Johnson Matthey PLC (LSE:JMAT), the sustainable technologies group, revealed plans to sell its medical device components business to a private equity firm. Montagu Private Equity will pay £550 million on a cash-free debt-free basis for the FTSE 250 firm's division, a company update revealed.
JMPLY vs. AIQUY: Which Stock Is the Better Value Option?
Investors interested in stocks from the Chemical - Diversified sector have probably already heard of Johnson Matthey PLC (JMPLY) and Air Liquide (AIQUY). But which of these two stocks is more attractive to value investors?
Should Value Investors Buy Johnson Matthey (JMPLY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
JMPLY or AIQUY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Chemical - Diversified sector might want to consider either Johnson Matthey PLC (JMPLY) or Air Liquide (AIQUY). But which of these two stocks is more attractive to value investors?
Are Investors Undervaluing Johnson Matthey (JMPLY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
JMPLY or AVNT: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Chemical - Diversified sector might want to consider either Johnson Matthey PLC (JMPLY) or Avient (AVNT). But which of these two stocks offers value investors a better bang for their buck right now?
Should Value Investors Buy Johnson Matthey (JMPLY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
JMPLY Financial details
JMPLY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 55.93 | 75.75 | 80.09 | 83.65 | 81.6 | |
| Net income per share | 2.15 | 1.33 | 1.06 | -0.53 | 1.51 | |
| Operating cash flow per share | 1.74 | 2.6 | 3.51 | 2.75 | 1.23 | |
| Free cash flow per share | 0.62 | 0.3 | 1.53 | 0.38 | -0.5 | |
| Cash per share | 2.39 | 1.73 | 3.24 | 2.18 | 3.81 | |
| Book value per share | 13.59 | 14.67 | 13.93 | 12.74 | 13.87 | |
| Tangible book value per share | 9.22 | 6.59 | 6.32 | 7.53 | 8.33 | |
| Share holders equity per share | 13.59 | 14.67 | 13.93 | 12.74 | 13.87 | |
| Interest debt per share | 7.4 | 8.1 | 7.65 | 6.75 | 9.44 | |
| Market cap | 12.36B | 6.79B | 11.83B | 7.35B | 7.3B | |
| Enterprise value | 13.24B | 7.92B | 12.62B | 8.21B | 8.31B | |
| P/E ratio | 29.94 | 26.62 | 57.7 | -72.78 | 26.44 | |
| Price to sales ratio | 1.15 | 0.47 | 0.77 | 0.46 | 0.49 | |
| POCF ratio | 37.02 | 13.58 | 17.5 | 13.97 | 32.43 | |
| PFCF ratio | 103.9 | 119.09 | 40.1 | 100.69 | -80.19 | |
| P/B Ratio | 4.74 | 2.4 | 4.41 | 3.01 | 2.87 | |
| PTB ratio | 4.74 | 2.4 | 4.41 | 3.01 | 2.87 | |
| EV to sales | 1.23 | 0.54 | 0.82 | 0.51 | 0.56 | |
| Enterprise value over EBITDA | 18.57 | 11.24 | 19.18 | 12.07 | 12.02 | |
| EV to operating cash flow | 39.65 | 15.83 | 18.67 | 15.61 | 36.96 | |
| EV to free cash flow | 111.29 | 138.88 | 42.79 | 112.47 | -91.37 | |
| Earnings yield | 0.03 | 0.04 | 0.02 | -0.01 | 0.04 | |
| Free cash flow yield | 0.01 | 0.01 | 0.02 | 0.01 | -0.01 | |
| Debt to equity | 0.5 | 0.48 | 0.49 | 0.5 | 0.64 | |
| Debt to assets | 0.22 | 0.19 | 0.17 | 0.18 | 0.23 | |
| Net debt to EBITDA | 1.23 | 1.6 | 1.21 | 1.26 | 1.47 | |
| Current ratio | 1.64 | 1.32 | 1.35 | 1.33 | 1.51 | |
| Interest coverage | 5.25 | 2.77 | 3.25 | 6.13 | 5.61 | |
| Income quality | 0.81 | 1.96 | 3.48 | 4.53 | 0.85 | |
| Dividend Yield | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | |
| Payout ratio | 0.38 | 0.65 | 0.48 | -1.38 | 0.51 | |
| Sales general and administrative to revenue | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Research and developement to revenue | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.14 | 0.21 | 0.19 | 0.15 | 0.14 | |
| Capex to operating cash flow | -0.64 | -0.89 | -0.56 | -0.86 | -1.4 | |
| Capex to revenue | -0.02 | -0.03 | -0.02 | -0.03 | -0.02 | |
| Capex to depreciation | -1.38 | -2.49 | -2.24 | -2.56 | -1.69 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 25.64 | 20.92 | 18.26 | 12.29 | 21.7 | |
| ROIC | 0.12 | 0.1 | 0.1 | 0.08 | 0.09 | |
| Return on tangible assets | 0.08 | 0.04 | 0.03 | -0.02 | 0.05 | |
| Graham Net | -6.67 | -9.04 | -9.17 | -9.02 | -8.65 | |
| Working capital | 1.32B | 1.06B | 1.28B | 1.03B | 1.47B | |
| Tangible asset value | 1.77B | 1.27B | 1.22B | 1.44B | 1.52B | |
| Net current asset value | 35M | -195M | -185M | -41M | -122M | |
| Invested capital | 0.5 | 0.48 | 0.49 | 0.5 | 0.64 | |
| Average receivables | 1.17B | 1.64B | 2.18B | 2.04B | 1.78B | |
| Average payables | 617M | 657M | 836.5M | 874.5M | 792M | |
| Average inventory | 1.12B | 1.61B | 1.86B | 1.68B | 1.63B | |
| Days sales outstanding | 42.53 | 50.58 | 55.5 | 39.61 | 44.27 | |
| Days payables outstanding | 23.9 | 18.17 | 25.09 | 18.35 | 21.75 | |
| Days of inventory on hand | 49.37 | 51.06 | 45.69 | 37.75 | 44.55 | |
| Receivables turnover | 8.58 | 7.22 | 6.58 | 9.22 | 8.25 | |
| Payables turnover | 15.27 | 20.08 | 14.55 | 19.89 | 16.78 | |
| Inventory turnover | 7.39 | 7.15 | 7.99 | 9.67 | 8.19 | |
| ROE | 0.16 | 0.09 | 0.08 | -0.04 | 0.11 | |
| Capex per share | -1.12 | -2.3 | -1.98 | -2.36 | -1.73 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 44.53 | 39.09 | 40.04 | 41.58 | 35.65 | |
| Net income per share | -0.15 | -0.38 | 0.87 | 0.62 | 0.34 | |
| Operating cash flow per share | 1.96 | 0.78 | 0.64 | 0.59 | 1.1 | |
| Free cash flow per share | 1.01 | -0.64 | -0.1 | -0.39 | 0.24 | |
| Cash per share | 4.19 | 2.2 | 2.55 | 3.81 | 3.01 | |
| Book value per share | 13.86 | 12.83 | 13.9 | 13.88 | 13.28 | |
| Tangible book value per share | 6.49 | 7.58 | 8.25 | 8.33 | 7.71 | |
| Share holders equity per share | 13.86 | 12.83 | 13.9 | 13.88 | 13.28 | |
| Interest debt per share | 7.54 | 6.69 | 7.66 | 9.29 | 8.62 | |
| Market cap | 10.29B | 7.3B | 6.62B | 7.29B | 6.05B | |
| Enterprise value | 11B | 8.16B | 7.6B | 8.31B | 7.1B | |
| P/E ratio | -91.83 | -25.01 | 10.35 | 15.99 | 24.02 | |
| Price to sales ratio | 1.2 | 0.98 | 0.9 | 0.96 | 0.93 | |
| POCF ratio | 27.21 | 49.34 | 56.12 | 68.15 | 29.97 | |
| PFCF ratio | 53.02 | -60.35 | -348.56 | -101.28 | 137.57 | |
| P/B Ratio | 3.85 | 2.99 | 2.6 | 2.87 | 2.49 | |
| PTB ratio | 3.85 | 2.99 | 2.6 | 2.87 | 2.49 | |
| EV to sales | 1.28 | 1.1 | 1.04 | 1.09 | 1.09 | |
| Enterprise value over EBITDA | 29.9 | 27.03 | 25.17 | 21.98 | 27.95 | |
| EV to operating cash flow | 29.11 | 55.15 | 64.43 | 77.66 | 35.15 | |
| EV to free cash flow | 56.72 | -67.45 | -400.14 | -115.41 | 161.37 | |
| Earnings yield | 0 | -0.01 | 0.02 | 0.02 | 0.01 | |
| Free cash flow yield | 0.02 | -0.02 | 0 | -0.01 | 0.01 | |
| Debt to equity | 0.53 | 0.5 | 0.53 | 0.64 | 0.62 | |
| Debt to assets | 0.19 | 0.18 | 0.2 | 0.23 | 0.23 | |
| Net debt to EBITDA | 1.95 | 2.85 | 3.25 | 2.69 | 4.12 | |
| Current ratio | 1.34 | 1.33 | 1.38 | 1.51 | 1.51 | |
| Interest coverage | 7.08 | 3.56 | 4.44 | 4.52 | 2.24 | |
| Income quality | -13.5 | 1.03 | 0.79 | 0.94 | 3.21 | |
| Dividend Yield | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | |
| Payout ratio | -3.43 | -0.59 | 0.63 | 0.36 | 1.6 | |
| Sales general and administrative to revenue | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Intangibles to total assets | 0.19 | 0.15 | 0.15 | 0.14 | 0.16 | |
| Capex to operating cash flow | -0.49 | -1.82 | -1.16 | -1.67 | -0.78 | |
| Capex to revenue | -0.02 | -0.04 | -0.02 | -0.02 | -0.02 | |
| Capex to depreciation | -1.86 | -3.45 | -1.54 | -1.83 | -1.66 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 6.73 | 10.52 | 16.53 | 13.95 | 10.14 | |
| ROIC | 0.2 | 0.04 | 0.04 | 0.05 | 0.03 | |
| Return on tangible assets | 0 | -0.01 | 0.03 | 0.02 | 0.01 | |
| Graham Net | -8.22 | -9.08 | -8.4 | -8.66 | -7.86 | |
| Working capital | 1.21B | 1.03B | 1.16B | 1.47B | 1.3B | |
| Tangible asset value | 1.25B | 1.44B | 1.51B | 1.52B | 1.41B | |
| Net current asset value | -47M | -41M | -123M | -122M | -223M | |
| Invested capital | 0.53 | 0.5 | 0.53 | 0.64 | 0.62 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 20.18 | 21.04 | 23.34 | 21.43 | 24.36 | |
| Days payables outstanding | 8.01 | 9.77 | 33.76 | 31.65 | 33.47 | |
| Days of inventory on hand | 22.43 | 20.1 | 23.42 | 21.57 | 22.43 | |
| Receivables turnover | 4.46 | 4.28 | 3.86 | 4.2 | 3.69 | |
| Payables turnover | 11.23 | 9.21 | 2.67 | 2.84 | 2.69 | |
| Inventory turnover | 4.01 | 4.48 | 3.84 | 4.17 | 4.01 | |
| ROE | -0.01 | -0.03 | 0.06 | 0.04 | 0.03 | |
| Capex per share | -0.95 | -1.41 | -0.75 | -0.98 | -0.86 |
JMPLY Frequently Asked Questions
What is Johnson Matthey Plc stock symbol ?
Johnson Matthey Plc is a GB stock and trading under the symbol JMPLY
What is Johnson Matthey Plc stock quote today ?
Johnson Matthey Plc stock price is $44.71 today.
Is Johnson Matthey Plc stock public?
Yes, Johnson Matthey Plc is a publicly traded company.
Company Profile
- Volume Average 5.52K
- Market Capitalization 4.03B
- Employee 12.64K
- CEO Mr. Liam Condon
- Headquarters London,GB
- IPO Date 2010-01-20
-
Website
https://www.matthey.com 
Johnson Matthey Plc engages in the clean air, catalyst and hydrogen technology, and platinum group metals (PGM) service businesses in the United Kingdom, Germany, rest of Europe, the United States, rest of North America, China and Hong Kong, rest of Asia, and internationally. It operates through three segments: Clean Air, Efficient Natural Resources, and Other Markets. The Clean Air segment provides catalysts for emission control after-treatment systems to remove harmful emissions from vehicles, as well as cars, other light duty vehicles, trucks, buses, and non-road equipment powered by diesel and gasoline. The Efficient Natural Resources segment provides products and processing services for the use and transformation of critical natural resources including oil, gas, biomass, and platinum group metals; and circular economy solutions. This segment also offers specialty catalysts and additives; process technology and engineering design licenses; platinum group metal refining and recycling services, and chemical and industrial products; and other precious metal services. The Other Markets segment business portfolio includes precious metal pastes and enamels, battery systems, fuel cell technologies, battery materials, and green hydrogen; science and technology to develop the products for devices used in medical procedures; and detection, diagnostic, and measurement solutions. The company was formerly known as Johnson & Cock and changed its name to Johnson Matthey Plc in 1851. Johnson Matthey Plc was founded in 1817 and is based in London, the United Kingdom.
